Brief #79637Updated 18 NOV 2025NEW YORKMEDICAL ORGANIZATIONSSERIES A
Employbl DossierAethon Therapeutics
Aethon Therapeutics treats cancer by combining immunotherapy and targeted treatment to increase its effectiveness. Aethon's unique anti-drug-peptide conjugate/MHC antibodies are intended to be employed in conjunction…
- Founded
- 2022
- Headcount
- 13
- Open roles
- 0
- Last raised
- Series A · $30M
Section II · Premium ProfileMembers only
- 01Engineering interview process at Aethon TherapeuticsLocked
- 02Tech stack & infrastructure choicesLocked
- 03Culture & day-to-day work styleLocked
- 04Why join now vs. 6 months from nowLocked
- 05Hiring focus & open headcount by teamLocked
- 06Comp philosophy and band contextLocked
7-day free trial · $25/mo · cancel anytime
